Your browser doesn't support javascript.
loading
Dermatologic manifestations of solid organ transplantation-associated graft-versus-host disease: A systematic review.
Kim, Grace Y; Schmelkin, Leah A; Davis, Mark D P; El-Azhary, Rokea A; Farrell, Ann M; Meves, Alexander; Lehman, Julia S.
Afiliação
  • Kim GY; Mayo Clinic School of Medicine, Mayo Clinic, Rochester, Minnesota.
  • Schmelkin LA; Mayo Clinic School of Graduate Medical Education, Mayo Clinic, Rochester, Minnesota.
  • Davis MDP; Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
  • El-Azhary RA; Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
  • Farrell AM; Mayo Clinic Libraries, Mayo Clinic, Rochester, Minnesota.
  • Meves A; Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
  • Lehman JS; Department of Dermatology, Mayo Clinic, Rochester, Minnesota; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: lehman.julia@mayo.edu.
J Am Acad Dermatol ; 78(6): 1097-1101.e1, 2018 Jun.
Article em En | MEDLINE | ID: mdl-29288097
ABSTRACT

BACKGROUND:

Graft-versus-host-disease (GVHD) after solid organ transplantation (SOT) is extremely rare.

OBJECTIVE:

To investigate the dermatologic manifestations and clinical outcomes of SOT GVHD.

METHODS:

Systematic literature review of SOT GVHD.

RESULTS:

After full-text article review, we included 61 articles, representing 115 patients and 126 transplanted organs. The most commonly transplanted organ was the liver (n = 81). Among 115 patients, 101 (87.8%) developed skin involvement. The eruption appeared an average of 48.3 days (range, 3-243 days) posttransplant and was pruritic in 5 of 101 (4.9%) cases. The eruption was described as morbilliform in 2 patients (1.9%), confluent in 6 (5.9%), and desquamative in 4 (3.9%) cases. In many cases, specific dermatologic descriptions were lacking. The mortality rate was 72.2%. Relative time of death was reported in 23 patients who died during the follow-up period. These patients died an average of 99.2 days (range, 22-270 days) posttransplant, or 50.9 days after the appearance of dermatologic symptoms. Frequent causes of death were sepsis and multiorgan failure.

LIMITATIONS:

Incomplete descriptions of skin findings and potential publication bias resulting in publication of only the most severe cases.

CONCLUSIONS:

GVHD is a potentially fatal condition that can occur after SOT and often presents with a skin rash. We recommend that dermatologists have a low threshold to consider and pursue this diagnosis in the setting of post-SOT skin eruption.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatopatias / Transplante de Órgãos / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatopatias / Transplante de Órgãos / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article